Drug Type Small molecule drug |
Synonyms Hydroxyzine pamoate (JP17/USP), Atarax-P, VISTARIL + [2] |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (30 Sep 1965), |
Regulation- |
Molecular FormulaC44H43ClN2O8 |
InChIKeyASDOKGIIKXGMNB-UHFFFAOYSA-N |
CAS Registry10246-75-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01096 | Hydroxyzine Pamoate | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anxiety Disorders | United States | 15 Nov 1968 | |
Catatonia | United States | 15 Nov 1968 | |
Chronic Urticaria | United States | 15 Nov 1968 | |
Dermatitis, Contact | United States | 15 Nov 1968 | |
Hypersensitivity | United States | 15 Nov 1968 | |
Dermatitis | Japan | 30 Sep 1965 | |
Eczema | Japan | 30 Sep 1965 | |
Neurotic Disorders | Japan | 30 Sep 1965 | |
Pruritus | Japan | 30 Sep 1965 | |
Urticaria | Japan | 30 Sep 1965 |